🔗 Permalink

Inventor profile of:

George Fromm

City:

DURHAM, North Carolina

Country:

United States

Published Applications:

Last publication date:

2025-10-30

Top Assignees for applications by George Fromm

The entities that hold a legal rights for patent applications filed by inventor Fromm George:

Heat Biologics, Inc. 14 Durham, NC United States
Heat Biologies, Inc. 1 Durham, NC United States
Kopfkino IP, LLC 1 Austin, TX United States

Recent patent applications by Fromm George

George Fromm from DURHAM, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-30

US20250332219A1

Human necessities

COMPOSITIONS AND METHODS FOR ADJOINING TYPE I AND TYPE II EXTRACELLULAR DOMAINS AS HETEROLOGOUS CHIMERIC PROTEINS

#2 | 2023-01-10

US17479776

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#3 | 2021-01-07

US20210000945A1

Human necessities

VECTOR CO-EXPRESSING VACCINE AND COSTIMULATORY MOLECULES

#4 | 2020-08-20

US20200261537A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#5 | 2020-08-06

US20200246431A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#6 | 2020-04-02

US20200101136A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#7 | 2019-05-23

US20190151413A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#8 | 2019-01-03

US20190000967A1

Human necessities

Vector co-expressing vaccine and costimulatory molecules

#9 | 2018-12-20

US20180360955A1

Human necessities

Vector co-expressing vaccine and costimulatory molecules

#10 | 2018-11-15

US20180326008A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#11 | 2018-11-15

US20180326007A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#12 | 2018-11-15

US20180326006A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#13 | 2018-11-15

US20180326005A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#14 | 2018-11-15

US20180326004A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#15 | 2018-05-10

US20180125935A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#16 | 2018-03-08

US20180064787A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#17 | 2017-04-06

US20170095531A1

Human necessities

Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteins

#18 | 2016-09-01

US20160250322A1

Human necessities

Vector co-expressing vaccine and costimulatory molecules

InventorID:

1635509 ⎘